awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41847265-213FC268-352D-43D0-B720-EA621EC81CC3
Q41847265-213FC268-352D-43D0-B720-EA621EC81CC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41847265-213FC268-352D-43D0-B720-EA621EC81CC3
Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.
P2860
Q41847265-213FC268-352D-43D0-B720-EA621EC81CC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41847265-213FC268-352D-43D0-B720-EA621EC81CC3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
523ff0683d6b137ec8128ba1cb3efabf8ded5460
P2860
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.